| 发明名称 |
BIOMARKERS FOR OVARIAN CANCER |
| 摘要 |
The present invention provides protein-based biomarkers and biomarker combinations that am useful in qualifying ovarian cancer status in a patient. In particular, the biomarkers of this invention are useful to classify a subject sample as ovarian cancer, ovarian cancer of low malignant potential, benign ovarian disease or other malignant condition. The biomarkers can be detected by SELDI mass spectrometry. |
| 申请公布号 |
US2017089906(A1) |
申请公布日期 |
2017.03.30 |
| 申请号 |
US201615365652 |
申请日期 |
2016.11.30 |
| 申请人 |
VERMILLION, INC. ;THE UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION |
发明人 |
FUNG ERIC THOMAS;UELAND FREDERICK RAND;VAN NAGELL J.R.;DEPRIEST PAUL DUANE;BARON ANDRE THOMAS |
| 分类号 |
G01N33/574;G01N33/543 |
主分类号 |
G01N33/574 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
1. A method for qualifying ovarian cancer status in a subject comprising:
(a) measuring by immunoassay or mass spectroscopy at least one biomarker in a biological sample selected from blood, serum, plasma, and ovarian cyst fluid from the subject using the composition of claim 32; and (b) correlating the measurement with ovarian cancer status. |
| 地址 |
AUSTIN TX US |
